Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- 11 New Drugs to Be Officially Approved in April
April 7, 2008
- Treatment Architecture Japan 2007 Published by Synix
March 31, 2008
- REGULATORY NEWS IN BRIEF
March 31, 2008
- GENERICS NEWS IN BRIEF
March 31, 2008
- OPINION／The Scuttlebutt on Pharma Takeovers
March 31, 2008
- 78 Generics of Amlodipine from 38 Companies Approved
March 31, 2008
- PET Facility Goes Bankrupt
March 31, 2008
- 16 APIs See Approval of 1st Generics
March 31, 2008
- 2 Former Company Employees Assigned to PMDA's Review Division within 2 Years of Employment
March 31, 2008
- BUSINESS NEWS IN BRIEF
March 31, 2008
- Reduction in Yakkasa Essential for Drug Pricing System Reform Proposed by Industry: FPMAJ President
March 31, 2008
- 2nd Dialogue Held by Korosho and FJPWA
March 31, 2008
- NBI and Pfizer to Initiate e-Detailing for Spiriva
March 31, 2008
- GSK Promotes Adoair Anticipating Lifting of 2-Week Limitation on Prescriptions
March 31, 2008
- Kissei Has Candidate for Next Global Strategic Product at PI: President Kanzawa
March 31, 2008
- MEDICAL DEVICE NEWS IN BRIEF
March 31, 2008
- Astellas to Enhance Global Management System
March 31, 2008
- R&D NEWS IN BRIEF
March 31, 2008
- Takeda Announces Restructuring of US Operations
March 31, 2008
- JAPhMed Seminar Covers Wide Range of Topics
March 31, 2008
ページ
Japan is ramping up its push to spread regional formularies nationwide, a policy expected to standardize treatments, strengthen supply resilience,…
We had just gotten off a call with a client in Europe, and we’d received a bit of an earful. “Philip,” the client pressed, “what can this candidate bring to us? We know what he does, but what has he…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…